Sign In to Follow Application
View All Documents & Correspondence

Process For Preparing A Cdk Inhibitor

Abstract: The present invention relates to the preparation of a CDK7 inhibitor having the structure of compound of formula (I). The invention described herein also relates to intermediates useful for preparing compound of formula (I) and methods of preparation of those intermediates.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
24 November 2023
Publication Number
51/2023
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

AURIGENE ONCOLOGY LIMITED
39-40, KIADB Industrial Area, Electronic City Phase II, Hosur Road, Bangalore 560100

Inventors

1. PODDUTOORI, Ramulu
#1-36, Peddampally, Jammikunta, Telangana, Karimnagar 505122
2. VIJAYKUMAR BHAT, Uday
#167, Ground floor, 6th cross, 28th Main Sector-1, HSR layout, Bangalore 560102
3. THIMMASANDRA SEETHAPPA, Devaraja
Ward No-31, Thimmasandra Village, Chintamani, Chikkaballapure 563125

Specification

We claim:
1. A method for preparing a compound of formula (I):
(I)
wherein the method comprising reacting a compound of formula (I’’’):
with a compound of formula (KRM-C1)
, wherein X is Br, Cl or I; Y is -B(OH)2 or
optionally substituted with 1, 2, 3 or 4 independently selected C1-4 alkyl substituents,
wherein the subscript n is 1 or 2.
2. The method of claim 1, wherein the compound of formula (I’’’) is prepared by reacting a
compound of formula (KRM-A1): with a compound of formula (KRMB): wherein X is Br, Cl or I.
3. The method of claim 2, wherein the compound of formula (KRM-A1) is prepared by a
method comprising:
Ref: 27207-IN
25
a) reacting a compound of formula (KRM-A2): with (1R,2R)-
cyclohexane-1,2-diamine to form a salt of formula: ;
b) recrystallizing the salt (5) to obtain salt (6) of formula: ;
and
c) treating the salt of formula (6) with an acid to obtain the compound of formula (KRMA1).
4. A method for preparing a compound of formula (I):
(I)
wherein the method comprising:
i. reacting a compound of formula (1) with a compound of formula
(2) to afford a salt of a formula (3) ;
Ref: 27207-IN
26
ii. recrystallizing the salt of formula (3) in a solvent (B) to obtain a salt of a formula
(4) ;
iii. treating a mixture comprising the salt of formula (4) and a solvent (C) with an acid
to generate compound of formula (KRM-A) ;
iv. reacting the compound of formula (KRM-A) with a compound of formula (KRMB) to afford a compound of formula (I’): ;
and
v. reacting the compound of formula (I’) with a compound of formula (KRM-C)
to obtain the compound of formula (I).
5. The method of claim 4, wherein the step i) is carried out in the presence of the solvent (A)
selected from acetone, dichloromethane, n-propyl acetate, acetonitrile, methanol, isopropyl
alcohol, isopropyl acetate, isobutanol, 2-butanol, 1-butanol, n-butyl acetate, 1-pentanol, 1-
propanol, chloroform, methyl acetate, isobutyl acetate, isobutanol, ethanol, water, or
mixtures thereof.
6. The method of claim 4, wherein the solvent (B) is acetone, acetonitrile, methanol,
isopropyl alcohol, isopropyl acetate, isobutanol, 1-pentanol, 1-propanol, ethanol, water,
or mixtures thereof.
7. The method of any one of claim4, wherein the solvent (C) is acetone, dichloromethane,
n-propyl acetate, acetonitrile, methanol, isopropyl acetate, isobutanol, 2-butanol, 1-
butanol, n-butyl acetate, 1-pentanol, 1-propanol, chloroform, methyl acetate, isobutyl
acetate, isobutanol or ethanol.
Ref: 27207-IN
27
8. The method of claim 4, wherein the compound of formula (I’) is prepared by reacting a
compound of formula (II’): with a deprotecting agent.
9. The method of claim 8, wherein the compound of formula (II’) is prepared by i) reacting
the compound of formula (KRM-A) with oxalyl chloride to generate a compound of
formula (KRM-D); and ii) reacting the compound of formula
(KRM-D) in situ with the compound of formula (KRM-B).
10. A compound of formula (III)
(III); wherein
R
2
is halo, methylsulfonyloxy, p-tolylsulfonyloxy, phenylsulfonyloxy or
trifluoromethylsulfonyloxy.
11. The compound of any one of claims 10, having the structure:
(KRM-A).
12. A compound of formula (IV):
(IV), wherein:
R
1
is C1-6 alkyl; and R2
is halo, methylsulfonyloxy, p-tolylsulfonyloxy,
phenylsulfonyloxy or trifluoromethylsulfonyloxy.
13. The compound of any one of claims 12, having the structure:

Documents

Application Documents

# Name Date
1 202347080070-STATEMENT OF UNDERTAKING (FORM 3) [24-11-2023(online)].pdf 2023-11-24
2 202347080070-FORM 1 [24-11-2023(online)].pdf 2023-11-24
3 202347080070-DECLARATION OF INVENTORSHIP (FORM 5) [24-11-2023(online)].pdf 2023-11-24
4 202347080070-COMPLETE SPECIFICATION [24-11-2023(online)].pdf 2023-11-24
5 202347080070-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [24-11-2023(online)].pdf 2023-11-24
6 202347080070-Proof of Right [02-04-2024(online)].pdf 2024-04-02